Wealth Way Finder
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Wealth Way Finder

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025
May 12, 2025
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Multiple New Multi-Commodity Targets
next post
House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’

Related Posts

Victoria Gold-Silver Exploration Update

June 5, 2025

Significant Expansion of Douglas River Uranium Project

August 8, 2025

Helium Stocks: 5 Biggest Canadian Companies in 2025

August 8, 2025

Locksley Advances Multiple Antimony & REE Workstreams

October 3, 2025

Silver Crown Royalties Announces Closing of First Tranche...

June 24, 2025

Exceptional Lithium Intercept Extends Red Mountain Discovery Further...

May 19, 2025

Sarama Files Memorial in US$242M Damages Claim Against...

November 3, 2025

Panelists: Silver in Bull Market, but Expect Price...

February 10, 2026

Appendix 4E

August 29, 2025

Crypto Market Recap: Metaplanet Buys 1,005 Bitcoin, REX...

July 1, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (210)
    • Investing (546)
    • Politics (663)
    • World (148)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: wealthwayfinder.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wealthwayfinder.com | All Rights Reserved